GLP-1 drugs may increase risk of vision loss from rare condition, FDA warns
The risk appears small and data is mixed, but FDA wants patients to be aware.
Next post
“He Ended Taylor”: After Taylor Swift Sued Her, Robbie Williams Now Comes To Pop Star’s Defense
